Skip to main content
Glama

Entity Profile

entity_profile
Read-onlyIdempotent

"Tell me about X" / "research Acme" / "brief me on Tesla" / "what does Apple do" / "company profile for Microsoft" / "give me the rundown on NVDA" / "everything you know about $TICKER" — full cross-source profile of a US public company in ONE parallel call. ALWAYS PREFER over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view. Fans out across SEC EDGAR, XBRL, USPTO patents, federal contracts (USAspending), FDA-licensed biologics (Purple Book), H-1B hiring (DOL LCA), news and GLEIF, and returns: cik + company_name (+ resolved_from/resolved_to when value was a name); recent_filings (up to 5 with pipeworx://edgar/company/{cik}/filings/{accession} URIs); fundamentals (LATEST 10-K Revenues + NetIncomeLoss + Cash, sorted period_end DESC); patents (USPTO PatentsView API sunset May 2025 — soft-fails until reactivated); federal_contracts (USAspending awards where the company is the recipient); fda_products (FDA-licensed biologics — vaccines, cell/gene therapies — from the Purple Book; a company with only small-molecule/generic drugs will show none here, that is expected, not a failure); hiring (H-1B sponsorship volume + salary range from DOL LCA filings); recent news mentions via GDELT→GNews fallback; LEI via GLEIF. sources_used / sources_failed say which of these actually returned data for THIS company — an empty section is a real "no data", not a bug. Pass a ticker ("AAPL"), zero-padded CIK ("0000320193"), OR a company name ("Moderna") — names now resolve via SEC EDGAR's company-name match; a private company (no CIK/ticker) returns resolved:false with an explicit notes line, not a bare failure. type accepts "company" or "ticker" interchangeably — both take the same value shapes above.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYes"company" or "ticker" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon.
valueYesTicker (e.g., "AAPL"), zero-padded CIK (e.g., "0000320193"), or company name (e.g., "Moderna") — names resolve via SEC EDGAR company-name match.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. Only \"company\" supported today; person/place coming soon."New value: +"\"company\" or \"ticker\" — both are accepted and behave identically; `value` can be a ticker, CIK, or company name either way. person/place coming soon."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "ticker"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker (e.g., \"AAPL\") or zero-padded CIK (e.g., \"0000320193\"). Names not supported — use resolve_entity first if you only have a name."New value: +"Ticker (e.g., \"AAPL\"), zero-padded CIK (e.g., \"0000320193\"), or company name (e.g., \"Moderna\") — names resolve via SEC EDGAR company-name match."
  2. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description discloses behaviors far beyond the annotations: USPTO PatentsView soft-fails after May 2025, expected empty fda_products for small-molecule companies, sources_used/sources_failed semantics, GDELT→GNews fallback, and private-company resolved:false with an explicit notes line. These are exactly the kind of non-obvious behaviors an agent needs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but information-dense, front-loading purpose and usage preference before diving into output sections and edge cases. Each major clause earns its place, but the single-paragraph format and long inline list of sources make it harder to scan than a structured summary, so it is not a 5.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining return values, and it does so thoroughly: every returned section is named, failure and empty-data semantics are clarified, and input edge cases are covered. An agent has enough context to invoke the tool correctly and interpret its results.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description adds meaningful semantic detail: type accepts 'company' or 'ticker' interchangeably, names resolve via SEC EDGAR, and name inputs may produce resolved_from/resolved_to. This raises the score above baseline, though the schema already documents the core parameter shapes.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user phrasings and immediately states the tool returns a 'full cross-source profile of a US public company in ONE parallel call.' It names the exact resources searched and enumerates the returned sections, so an agent can clearly distinguish this broad profile tool from narrower sibling lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says to 'ALWAYS PREFER' this tool over chaining single-pack SEC/XBRL/news lookups when the user asks for a holistic view, and it specifies valid inputs including tickers, CIKs, and names. It does not explicitly address when to choose overlapping siblings like deep_research or compare_entities instead, so it falls just short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation3/5

Several tools have overlapping purposes, such as ask_pipeworx, ask_pipeworx_grounded, and deep_research all answering questions with slight differences. Also, entity_profile and compare_entities both retrieve company data, and the multitude of Polymarket tools can be confusing. However, many tools have distinct use-cases, so the ambiguity is moderate.

Naming Consistency3/5

Tool names mix consistent patterns (e.g., get_air_quality, get_apod) with less predictable ones (e.g., pipeworx_feedback, polymarket_arbitrage, bet_research). Some follow verb_noun, others are noun_verb or just noun. The inconsistency is noticeable but not chaotic.

Tool Count2/5

With 34 tools, the server feels overloaded for a 'science' domain. Many tools are dedicated to prediction markets (Polymarket) and finance, which seem tangential. The count could be reduced by merging similar query tools or removing domain-specific betting tools to better fit the scientific theme.

Completeness2/5

While the server covers a broad range of data sources (SEC, FDA, FRED, etc.), it lacks core scientific tools for physics, chemistry, or biology. The few science-themed tools (get_apod, get_earthquakes) are minor. The set feels incomplete for a dedicated science server, with emphasis on finance and betting instead.